We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy

Gastroenterology

0

GELSECTAN® launched in Finland

We are glad to announce the launch of GELSECTAN® in Finland by our partner company Sabora. GELSECTAN® belongs to a new class of products defined as “mucosal protectors”, which help restore the normal function of the epithelial barrier in the gut. It is intended to relieve and prevent IBS symptoms such as chronic or relapsing diarrhea, pain and bloating.

Read more

CORPORATE MEDIA RELEASE - NORGINE EXPANDS ITS PARTNERSHIP WITH NOVENTURE TO COMMERCIALISE GELSECTAN® IN FRANCE

Amsterdam. March 5th 2019. Norgine B.V. today announced that it has expanded its partnership with Noventure S.L. by entering into an exclusive distribution agreement for GELSECTAN® in France. This deal expands on Norgine’s existing collaboration with Noventure S.L. under which Norgine distributes GELSECTAN® in Portugal, Spain, Andorra and the Italian Republic (incl. Vatican City and San Marino). GELSECTAN ® is a Class IIa CE marked medical device used as a treatment for irritable bowel syndrome (IBS) with diarrhoea (IBS-D). IBS is a chronic bowel problem, characterized by abdominal pain, bloating, and changes in bowel habit. 1 Diarrhoea is one of the symptoms often associated with irritable bowel syndrome. GELSECTAN® is available in capsules for oral use.

Read more

Let's meet in..

2019, Jun 01

EAACI Congress 2019

Read more

2019, Jun 03

euroPLX 70 Berlin

Read more

2019, Jun 05

ESPGHAN 52

Read more

2019, Jun 13

Réunion annuelle du Groupe Français de Neuro-Gastroentérologie GFNG 2019

Read more

2019, Jun 14

Gastro Update Europe 2019

Read more

2019, Sep 05

NeuroGASTRO 2019

Read more

2019, Oct 19

UEG Week 2019

Read more